Nathan Gray

Nathan Gray is a seasoned professional in the biopharmaceutical and diagnostics industries, currently serving as Commercial Director at Eramol since July 2025. Previously, Nathan held the position of Eurofins BioPharma Business Development Director from January 2020 to July 2025, where responsibilities included leading the UK commercial efforts for GMP product testing across various sectors including pharma and biotech. With a diverse background, Nathan has also served as Eurofins Genomics Senior National Manager for the UK & Ireland and held roles at Novacyt Group, Johnson & Johnson MedTech, PATHWAY DIAGNOSTICS LIMITED, and RANDOX FOOD DIAGNOSTICS LIMITED. Nathan's educational foundation includes a First Class Bachelor’s Degree in Biological Sciences from Heriot-Watt University.